Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-132401
Filing Date
2024-12-02
Accepted
2024-12-02 19:50:40
Documents
1
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6735
  Complete submission text file 0000950170-24-132401.txt   8193
Mailing Address C/O REPLIMUNE GROUP, INC. 18 COMMERCE WAY WOBURN MA 01801
Business Address
Esposito Pamela (Reporting) CIK: 0001744425 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 241520624

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)